US EditionJ&J strikes deal with US government to cut drug prices, gain tariff exemptions
Johnson & Johnson commits to a $55 billion U.S. investment plan, expanding manufacturing and providing Medicaid access at prices aligned with other developed countries.
- On Jan 8, Johnson & Johnson announced it reached an agreement to cut U.S. drug prices in exchange for tariff exemptions, which it said `meets the requests` of U.S. President Donald Trump.
- The Trump administration had pressed manufacturers as U.S. patients often pay nearly three times more for medicines, reaching December agreements with nine other major pharmaceutical companies to cut Medicaid and cash prices promising `massive savings`.
- J&J will participate in TrumpRx.gov, listing discounted medicines to help Americans buy drugs at reduced rates and provide Medicaid access at prices comparable with other developed countries.
- J&J said it will build two new manufacturing facilities in North Carolina and Pennsylvania as part of its $55 billion U.S. investment plan and may announce more investments later this year.
- Using trade policy leverage, the agreement trades tariff exemptions for domestic drug-price cuts, supporting the administration's broader pricing push to align U.S. costs with other wealthy countries.
20 Articles
20 Articles
Johnson & Johnson announces drug pricing deal with Trump administration
Johnson & Johnson said late Thursday it will lower prices for certain prescription drugs and match the rates in other countries, becoming the latest pharmaceutical company to strike a deal with the Trump administration in exchange for tariff relief. The New Jersey-based health conglomerate was one of the 17 companies President Trump called out last summer to lower drug prices as part of his administration’s…
Johnson & Johnson Secures Tariff Exemption Deal In Exchange For Drug Price Cuts - Johnson & Johnson (NYSE:JNJ)
Johnson & Johnson (NYSE:JNJ) struck a deal with the Trump administration on Thursday to lower drug prices for U.S. consumers in exchange for exemptions from tariffs. The details of the agreement remain undisclosed, including the updated pricing and the specific drugs involved. Johnson & Johnson has pledged to offer its medicines at substantially reduced prices via the TrumpRx.gov website and to extend Medicaid access at rates comparable to those…
The Epoch Times
America First ReportJohnson & Johnson Reaches Agreement With Trump Admin to Cut Drug Prices
Johnson & Johnson (J&J) said on Jan. 8 that it has struck a voluntary deal with the Trump administration to lower drug prices for U.S. patients in exchange for tariff relief. In a statement, the pharmaceutical and medical technology company said it will participate in the TrumpRx.gov platform to allow Americans to purchase its medicines at “significantly discounted rates” and to provide Medicaid program access at prices comparable to those in ot…
J&J Reaches Deal With Trump For Drug Discounts, Tariff Reprieve
Johnson & Johnson reached a deal with the US government to lower drug prices for some Americans, joining a cadre of major pharmaceutical companies to make price concessions in exchange for tariff exemption.
Coverage Details
Bias Distribution
- 67% of the sources are Center
Factuality
To view factuality data please Upgrade to Premium
